When medically complex children are hospitalized, linking hospitalists to their regular outpatient providers through an inpatient consultation service were more likely to improve outcomes, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).
- Cardiothoracic & Vascular Surgery
- Children's Health Stories
- Coronavirus Español
- COVID-19 Patient Resources
- Ear, Nose, and Throat Stories
- Heart Care
- In the Media
- In the Media Español
- Patient Stories
- Pediatric Surgery
- UTHealth COVID-19 Research
- UTHealth Research
- Women's Health Stories
Research unlocks new information about reading through visual dictionary in the brain
The uniquely human ability to read is the cornerstone of modern civilization, yet very little is understood about the effortless ability to derive meaning from written words. Scientists at UTHealth have now identified a crucial region in the temporal lobe, know as the mid-fusiform cortex, which appears to act as the brain’s visual dictionary.
Patient with aortic aneurysm benefits from innovative, minimally invasive procedure
When Rodolfo Sandoval was told he would need to undergo open surgery to repair his thoracic and abdominal aortic aneurysm, he hesitated. At 73 years old, he was worried about the recovery process for a major, invasive procedure. Then COVID-19 arrived and he made the decision that he would only consider the surgery if it became a life or death situation.
Physicians investigate whether magnetic seizure therapy can treat bipolar depression
Researchers are assessing whether magnetic seizure therapy (MST) can help relieve treatment-resistant depression in bipolar patients in a clinical trial led by UTHealth.
Neurologists test novel compound for lung and brain injury in severe COVID-19 patients
Neurologists are researching whether a novel immunomodulatory treatment, OP-101, can dampen lung and brain injury in hospitalized COVID-19 patients through a clinical trial at The University of Texas Health Science Center at Houston (UTHealth).
Providing a safe environment for psychiatric patients during pandemic
The very heart of inpatient care for psychiatric patients is socialization, group therapy, shared meals, and a standard two people per room. Then COVID-19 hit with the accompanying public health warnings to isolate, socially distance, and wear masks. UTHealth HCPC had to walk the line between the two.
Study seeks to help boost understanding of deep brain stimulation for essential tremor
A high-tech imaging study to understand how brain connectivity patterns change after deep brain stimulation in patients suffering from essential tremor has been launched at The University of Texas Health Science Center at Houston (UTHealth).
Researchers receive $3.1 million to fund four-dimensional work on Down syndrome
To better understand the molecular basis of Down syndrome, a genetic disease that affects 1 in 750 infants born in the U.S., researchers at The University of Texas Health Science Center at Houston (UTHealth) have received a $3.1 million grant from the National Institutes of Health (NIH).
Pregnant Hispanic patients more likely to contract COVID-19 than other racial-ethnic groups
Pregnant Hispanic patients were nearly twice as likely to be diagnosed with COVID-19 than other racial-ethnic groups and most were asymptomatic, according to research by The University of Texas Health Science Center at Houston (UTHealth).
$3 million grant to further study how neurons work together
Studying how neurons work together in order to better understand neurological disorders such as Alzheimer’s disease and autism spectrum disorders, researchers led by John Byrne, PhD, at The University of Texas Health Science Center at Houston (UTHealth) have been awarded more than $3 million from the National Institutes of Health BRAIN Initiative.
Researchers receive more than $53 million to study role of white matter lesions in dementia
A $53.6 million grant from the National Institutes of Health will aid brain scientists, including a researcher from The University of Texas Health Science Center at Houston (UTHealth), in studying the role of incidental white matter lesions, or WMLs, in dementia among diverse people with cognitive complaints.
Pioneering research shows the benefits and risks of treating appendicitis with antibiotics instead of surgery
Results of a first-of-its-kind clinical trial shed light on when antibiotics instead of surgery might be the better choice for treating appendicitis in some patients, according to researchers with The University of Texas Health Science Center at Houston (UTHealth), who led the Houston trial sites.
$5 million NIH grant awarded to reduce COVID-19-related disparities in vulnerable populations
To help reduce COVID-19-related health disparities in vulnerable populations in Texas, a multi-institutional team of researchers led by The University of Texas Health Science Center at Houston (UTHealth) will identify disease hotspots and testing deserts in three racially diverse areas, and then develop and evaluate intervention strategies to increase COVID-19 testing.
First Houston post-coronavirus clinic part of new UTHealth COVID-19 Center of Excellence
Bringing together expertise and access to the best clinical care, research trials, discovery science, and public health knowledge, The University of Texas Health Science Center at Houston (UTHealth) has established the UTHealth COVID-19 Center of Excellence.
Researchers studying new nonsurgical treatment for chronic sinusitis
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are investigating the efficacy and safety of an intranasal treatment for adults with chronic sinusitis with or without nasal polyps.
Clinical trial to assess rehabilitation treatment for infants and toddlers after stroke
In the first of its kind for the tiniest stroke survivors, researchers at The University of Texas Health Science Center at Houston (UTHealth) will lead a stroke rehabilitation clinical trial in the state of Texas through a multi-institutional NIH StrokeNet initiative.
Placenta accreta month: Novel approach to life-threatening pregnancy condition allows woman to have “miracle child” after loss
Margarita Saavedra was 35 years old and 18 weeks pregnant with her second child when she fainted at the doctor’s office after receiving the news that she might need to have a hysterectomy to remove her uterus.
Could the time of day impact the effectiveness of COVID-19 treatment?
For months, experts have warned against the use of anti-inflammatory medications, such as ibuprofen, to treat COVID-19 symptoms. But could the timing of when this drug is taken play a role in its effectiveness?
- Young Houston woman recovers from COVID-19 after participation in two UTHealth clinical trials Heba Hajjar, 23, recovered from COVID-19 after participating in two clinical trials through The University of Texas Health Science Center at Houston (UTHealth) while in the intensive care unit (ICU) at Memorial Hermann-Texas Medical Center. She was so weak she couldn’t move or sit up in bed. She was cautiously monitored on oxygen therapy and […]
- Researchers assess whether blood plasma product could reduce hemorrhaging, improve survival rate of trauma patients The early use of a highly concentrated blood plasma called cryoprecipitate that could reduce deaths from hemorrhaging in trauma patients is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth) as part of an international trial. The UTHealth Center for Translational Injury Research is launching the Houston site of […]
- Team is first in Texas to join NIH-sponsored study investigating efficacy of convalescent plasma for COVID-19 Using a multimillion-dollar grant from the National Institutes of Health, physician-scientists at The University of Texas Health Science Center at Houston (UTHealth) will investigate whether convalescent plasma infusions can prevent the progression of COVID-19 in one of the first randomized clinical trials in the country. As part of the Center for Clinical and Translational Sciences, […]
- Maternal obesity increases risk of potentially deadly hypertensive disorders early in pregnancy Pregnant obese women were more at risk of experiencing early and late-onset hypertensive disorders, and that risk progressively increased in women with higher body mass indexes (BMI), according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth). The retrospective cohort study was recently published in Obstetrics Gynecology. […]
- Flu vaccine may reduce risk of Alzheimer’s disease, new study shows People who received at least one flu vaccination were 17% less likely to get Alzheimer’s disease over the course of a lifetime, according to researchers at The University of Texas Health Science Center at Houston (UTHealth). First author Albert Amran, a fourth-year medical student at McGovern Medical School at UTHealth, presented the findings at the […]
- Maternal depression increases odds of depression in offspring, study shows Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%, according to a new study by researchers at The University of Texas Health Science Center at Houston (UTHealth). The systematic review was recently published in JAMA Network Open. It is the first study to examine […]
- COVID-19 patient at LBJ Hospital recovers after convalescent plasma transfusion More than a month after her battle with COVID-19, Kony Chacon enjoys spending time with newborn daughter and shows no ill effects from the virus that jeopardized her life and that of her unborn child. She credits a century-old treatment now being used to help coronavirus patients fight off the infection – convalescent blood plasma […]
- Researchers study whether vadadustat, an investigational therapy, could mitigate acute lung injury in COVID-19 patients Physicians are studying whether vadadustat, an investigational therapy, could protect the lungs of COVID-19 patients by triggering the body’s protective response to low oxygen levels in a randomized Phase II clinical trial at The University of Texas Health Science Center at Houston (UTHealth). Vadadustat is designed to mimic the physiologic response to hypoxia (low oxygen). […]